Heart Division, Royal Brompton Hospital, London, United Kingdom.
Catheter Cardiovasc Interv. 2020 Jul;96(1):228-235. doi: 10.1002/ccd.28658. Epub 2019 Dec 18.
Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is an established therapy for a degenerated surgical bioprosthesis. TAVI-in-TAVI following ViV-TAVI has not been previously performed. We report a high-risk patient presenting with severe left ventricular failure secondary to undiagnosed critical aortic stenosis due to degeneration of the implanted transcatheter heart valve more than a decade after initial ViV-TAVI for a failing stentless aortic valve homograft. Successful TAVI-in-TAVI reversed the clinical and echocardiographic changes of decompensated heart failure with no evidence of coronary obstruction.
经导管主动脉瓣置换术(ViV-TAVI)治疗退行性外科生物瓣是一种成熟的方法。在 ViV-TAVI 之后进行 TAVI-in-TAVI 此前尚未进行过。我们报告了一位高危患者,由于最初的 ViV-TAVI 用于支架瓣主动脉同种异体移植物失效后,植入的经导管心脏瓣膜退行性病变导致未诊断的严重主动脉瓣狭窄,继发严重左心衰竭。成功的 TAVI-in-TAVI 逆转了心力衰竭失代偿的临床和超声心动图变化,无冠状动脉阻塞证据。